Sage Therapeutics, Inc. (SAGE) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 8.68 |
| Open | 8.68 |
| Day High | 8.68 |
| Day Low | 8.68 |
| 52-Week High | 9.36 |
| 52-Week Low | 4.62 |
| Volume | 17.39M |
| Average Volume | 2.48M |
| Market Cap | 544.94M |
| PE | -1.78 |
| EPS | -4.89 |
| Moving Average 50 Days | 8.29 |
| Moving Average 200 Days | 7.13 |
| Change | 0 |
Data not available
Sage Potash Announces Promotion of Patricio Varas to Permanent CEO and His Appointment to the Board of Directors
Newsfile
Jan 29, 2026 1:30 PM GMT
Vancouver, British Columbia--(Newsfile Corp. - January 29, 2026) - Further to the closing yesterday of the second and final tranche of its highly successful $13M private placement equity financing, Sage Potash Corp. (TSXV: SAGE) (OTCQB: SGPTF) ("Sage
Sage Potash Closes Second and Final Tranche of Unit Offering
Newsfile
Jan 28, 2026 10:00 PM GMT
Vancouver, British Columbia--(Newsfile Corp. - January 28, 2026) - Sage Potash Corp. (TSXV: SAGE) (OTCQB: SGPTF) ("Sage Potash" or the "Company") is pleased to announce that further to its news releases of December 15, 2025, and December 23, 2025, th
Sage Potash Closes First Tranche of Unit Financing
Newsfile
Dec 23, 2025 11:35 PM GMT
Vancouver, British Columbia--(Newsfile Corp. - December 23, 2025) - Sage Potash Corp. (TSXV: SAGE) (OTCQB: SGPTF) ("Sage Potash" or the "Company") is pleased to announce that it has closed a first tranche of its previously announced unit private plac